NADH Cancer Research Results

NADH, Nicotinamide Adenine Dinucleotide: Click to Expand ⟱
Source:
Type:
NADH is the reduced form of NAD⁺, meaning it has accepted electrons (and usually a proton) during metabolic reactions. When NAD⁺ accepts electrons (typically during metabolic processes like glycolysis, the citric acid cycle, and beta-oxidation), it becomes NADH.
-By influencing the balance between NADH and NAD⁺, ENOX2 might shift the cellular redox state. An imbalance can lead to increased oxidative stress or changes in ROS signaling pathways.

• The ratio between NADH and NAD⁺ is a key indicator of a cell’s metabolic state.
• Some studies have suggested that abnormal NADH metabolism or shifts in the NADH/NAD⁺ ratio can be correlated with tumor aggressiveness or response to therapy.
• For example, in certain cancers, a higher NADH/NAD⁺ ratio may be associated with more aggressive behavior, resistance to apoptosis, or poor prognosis.


Scientific Papers found: Click to Expand⟱
175- Api,    Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT
- vitro+vivo, CRC, SW480 - vitro+vivo, CRC, DLD1 - vitro+vivo, CRC, LS174T
MMP↓, p‑Akt↓, TumCP↓, TumCI↓, NADH↓, HSP90↓, other↑, talin?,
5833- CAP,    Capsaicin: From Plants to a Cancer-Suppressing Agent
- Review, Var, NA
chemoPv↑, TumCCA↑, Apoptosis↑, ROS↑, MMP↓, Ca+2↑, JNK↑, Casp3↑, NADH↓, CDK2↓, CDK4↓, CDK6↓, P53↑,
5858- CAP,    Capsaicin as a Microbiome Modulator: Metabolic Interactions and Implications for Host Health
- Review, Nor, NA - Review, AD, NA
*BBB↓, *GutMicro↑, Obesity↓, *Inflam↓, *AntiCan↑, *TRPV1↑, *Ca+2↑, *antiOx↑, *cardioP↑, *BioAv↓, *Half-Life↓, *BioAv↝, *BioAv↑, *neuroP↑, Apoptosis↑, p38↑, ROS↑, MMP↓, MPT↑, Cyt‑c↑, Casp↑, TRIB3↑, NADH↓, SIRT1↓, TumCG↓, TumCMig↓, TOP1↓, TOP2↓, β-catenin/ZEB1↓, *ROS↓, *Aβ↓,
1586- Citrate,    Extracellular Citrate Is a Trojan Horse for Cancer Cells
- in-vitro, Liver, HepG2
Dose?, ac‑H4↓, lipidDe↓, ACLY↓, selectivity↑, *ACLY∅, Glycolysis↓, NADH↓, OAA↑, other↑,
1891- MGO,    Methylglyoxal induces mitochondria-dependent apoptosis in sarcoma
- in-vitro, SCC, NA
NADH↓, MMP↓, Cyt‑c↑, selectivity↑, Apoptosis↑, ROS↑, ATP↓,
5904- TV,    Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development
- Review, Var, NA - Review, Stroke, NA - Review, Diabetic, NA - Review, Obesity, NA - Review, AD, NA - Review, Arthritis, NA
*antiOx↑, *ROS↓, *Inflam↓, *Bacteria↓, AntiTum↑, IronCh↑, *HDL↑, *LDL↓, *BioAv↝, *Half-Life↝, *BioAv↑, *SOD↑, *GPx↑, *GSTs↑, *eff↑, radioP↑, *MDA↓, *other↑, *COX1↓, *COX2↓, *AntiAg↑, *RNS↓, *NO↓, *H2O2↓, *NOS2↓, *NADH↓, *Imm↑, Apoptosis↑, TumCP↓, angioG↓, TumCMig↓, Ca+2↑, TumCCA↑, DNAdam↑, BAX↑, Casp9↑, Casp8↑, Casp3↑, cl‑PARP↑, AIF↑, i-ROS↑, MMP↓, Cyt‑c↑, APAF1↑, Ca+2↑, MMP9↓, MMP2↓, PKCδ↓, ERK↓, H2O2↑, BAX↑, Bcl-2↓, DNAdam↑, lipid-P↑, ChemoSen↑, chemoP↑, *cardioP↑, *SOD↑, *Catalase↑, *GPx↑, *GSH↑, *BP↓, *AntiDiabetic↑, *Obesity↓, RenoP↑, *GastroP↑, hepatoP↑, *AChE↓, *cognitive↑, *BChE↓, *other↓, *BioAv↑,

Showing Research Papers: 1 to 6 of 6

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

H2O2↑, 1,   lipid-P↑, 1,   lipidDe↓, 1,   NADH↓, 5,   ROS↑, 3,   i-ROS↑, 1,  

Metal & Cofactor Biology

IronCh↑, 1,  

Mitochondria & Bioenergetics

AIF↑, 1,   ATP↓, 1,   MMP↓, 5,   MPT↑, 1,  

Core Metabolism/Glycolysis

ACLY↓, 1,   Glycolysis↓, 1,   OAA↑, 1,   SIRT1↓, 1,  

Cell Death

p‑Akt↓, 1,   APAF1↑, 1,   Apoptosis↑, 4,   BAX↑, 2,   Bcl-2↓, 1,   Casp↑, 1,   Casp3↑, 2,   Casp8↑, 1,   Casp9↑, 1,   Cyt‑c↑, 3,   JNK↑, 1,   p38↑, 1,  

Transcription & Epigenetics

ac‑H4↓, 1,   other↑, 2,  

Protein Folding & ER Stress

HSP90↓, 1,  

DNA Damage & Repair

DNAdam↑, 2,   P53↑, 1,   cl‑PARP↑, 1,  

Cell Cycle & Senescence

CDK2↓, 1,   CDK4↓, 1,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State

ERK↓, 1,   TOP1↓, 1,   TOP2↓, 1,   TumCG↓, 1,  

Migration

Ca+2↑, 3,   MMP2↓, 1,   MMP9↓, 1,   PKCδ↓, 1,   talin?, 1,   TRIB3↑, 1,   TumCI↓, 1,   TumCMig↓, 2,   TumCP↓, 2,   β-catenin/ZEB1↓, 1,  

Angiogenesis & Vasculature

angioG↓, 1,  

Hormonal & Nuclear Receptors

CDK6↓, 1,  

Drug Metabolism & Resistance

ChemoSen↑, 1,   Dose?, 1,   selectivity↑, 2,  

Clinical Biomarkers

TRIB3↑, 1,  

Functional Outcomes

AntiTum↑, 1,   chemoP↑, 1,   chemoPv↑, 1,   hepatoP↑, 1,   Obesity↓, 1,   radioP↑, 1,   RenoP↑, 1,  
Total Targets: 63

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx↑, 2,   Catalase↑, 1,   GPx↑, 2,   GSH↑, 1,   GSTs↑, 1,   H2O2↓, 1,   HDL↑, 1,   MDA↓, 1,   NADH↓, 1,   RNS↓, 1,   ROS↓, 2,   SOD↑, 2,  

Core Metabolism/Glycolysis

ACLY∅, 1,   LDL↓, 1,  

Cell Death

TRPV1↑, 1,  

Transcription & Epigenetics

other↓, 1,   other↑, 1,  

Migration

AntiAg↑, 1,   Ca+2↑, 1,  

Angiogenesis & Vasculature

NO↓, 1,  

Barriers & Transport

BBB↓, 1,   GastroP↑, 1,  

Immune & Inflammatory Signaling

COX1↓, 1,   COX2↓, 1,   Imm↑, 1,   Inflam↓, 2,  

Synaptic & Neurotransmission

AChE↓, 1,   BChE↓, 1,  

Protein Aggregation

Aβ↓, 1,  

Drug Metabolism & Resistance

BioAv↓, 1,   BioAv↑, 3,   BioAv↝, 2,   eff↑, 1,   Half-Life↓, 1,   Half-Life↝, 1,  

Clinical Biomarkers

BP↓, 1,   GutMicro↑, 1,   NOS2↓, 1,  

Functional Outcomes

AntiCan↑, 1,   AntiDiabetic↑, 1,   cardioP↑, 2,   cognitive↑, 1,   neuroP↑, 1,   Obesity↓, 1,  

Infection & Microbiome

Bacteria↓, 1,  
Total Targets: 45

Scientific Paper Hit Count for: NADH, Nicotinamide Adenine Dinucleotide
2 Capsaicin
1 Apigenin (mainly Parsley)
1 Citric Acid
1 Methylglyoxal
1 Thymol-Thymus vulgaris
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1120  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page